Regular intake of sugary beverages, but not diet soda, is associated with prediabetes

November 09, 2016

BOSTON (Nov. 9, 2016) -- Adult Americans who regularly consumed sugar-sweetened beverages (roughly one can of soda per day) had a 46 percent higher risk of developing prediabetes compared to low- or non-consumers over a 14-year period, according to a new epidemiological analysis led by scientists at the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University. Higher sugar-sweetened beverage intake was also associated with increased insulin resistance, a risk factor for type 2 diabetes.

No associations between diet soda consumption and risk of prediabetes or increased insulin resistance were found. However, the research team notes that previous studies on associations between diet soda and risk of type 2 diabetes have produced mixed results, and further studies are needed to reveal the long-term health impact of artificially sweetened drinks. The findings were published in the Journal of Nutrition on Nov. 9.

"Although our study cannot establish causality, our results suggest that high sugar-sweetened beverage intake increases the chances of developing early warning signs for type 2 diabetes. If lifestyle changes are not made, individuals with prediabetes are on the trajectory to developing diabetes," said senior study author Nicola McKeown, Ph.D., scientist in the Nutritional Epidemiology Program at the USDA HNRCA.

"Our findings support recommendations to limit sugar-sweetened beverage intake, which can be achieved by replacing sugary beverages with healthier alternatives such as water or unsweetened coffee or tea," added McKeown, who is also an associate professor at the Friedman School of Nutrition Science and Policy at Tufts. "This is a simple dietary modification that could be of substantial health benefit to people who consume sugary drinks daily and who are at increased risk of diabetes."

In the current study, McKeown and her colleagues analyzed longitudinal data on 1,685 middle-aged adults over a period of 14 years, obtained from the Framingham Heart Study's Offspring cohort -- a National Heart, Lung, and Blood Institute-funded program that has monitored multiple generations for lifestyle and clinical characteristics that contribute to cardiovascular disease. Selected participants did not have diabetes or prediabetes during an initial baseline examination and self-reported their long-term sugar-sweetened beverage and diet soda consumption habits through food frequency questionnaires. Sugar-sweetened beverages were defined as colas and other carbonated beverages, and non-carbonated fruit drinks such as lemonade and fruit punch. Fruit juice was not included in the sugar-sweetened beverage category.

The team found those who drank the highest amounts of sugar-sweetened beverages -- a median of six 12 fluid ounce servings a week -- had a significantly greater risk of developing prediabetes compared to low- or non-consumers, after adjusting for factors such as age, sex and body mass index. The highest consumers of sugar-sweetened beverages had roughly 8 percent higher insulin resistance scores, compared to low- or non-consumers after follow-up at seven years. Even after accounting for change in weight and other aspects of diet, the relationships between sugar-sweetened beverages and these metabolic risk factors for diabetes persisted.

Diet soda intake -- defined as low-calorie cola or other carbonated low-calorie beverages -- had no statistical associations with risk for either prediabetes or insulin resistance. However, previous research on the relationship between diet soda and type 2 diabetes has been mixed, and it is still unclear whether any observed associations are due to direct or indirect factors. More research is needed to determine whether there are real health risks with long-term diet soda consumption, say the study authors. In addition, the authors caution that despite adjusting for multiple factors, residual confounding cannot be ruled out due to the observational nature of the study. Participants who were analyzed in the study were mostly middle-aged and Caucasian, more likely to be women, and had lower body mass index and waist circumference, which may limit the generalizability of the findings.

A significant body of research has found associations between regular consumption of sugar-sweetened beverages and increased risk of type 2 diabetes. The new findings now provide evidence of an association with the major predictor of type 2 diabetes. If diagnosed early, prediabetes is reversible through lifestyle changes such as diet and exercise.

"Based on our observational study alone, we cannot be certain why we saw the relationships we did. Additional studies are needed to fully understand the health impact of sugar-sweetened beverages and diet sodas," said lead study author Jiantao Ma, Ph.D., who conducted the analysis as part of his doctoral thesis as a student in the Nutrition Epidemiology Program at the USDA HNRCA and the Friedman School.

"Nevertheless, our data are consistent with many other studies and clinical trials that support the health benefits of reducing sugar intake, and we encourage the public to look for healthier options," added Ma, who is currently a postdoctoral fellow at the National Heart, Lung, and Blood Institute of the National Institutes of Health.
-end-
Additional authors of this study are Paul F. Jacques, D.Sc., director and senior scientist in the Nutritional Epidemiology Laboratory at the USDA HNRCA, James B. Meigs, M.D., professor of medicine at Harvard Medical School and physician in the division of general internal medicine at Massachusetts General Hospital, Caroline S. Fox, M.D., M.P.H., of the Framingham Heart Study of the National Heart, Lung, and Blood Institute of the National Institutes of Health, Gail T. Rogers, M.A., senior statistician in the Nutritional Epidemiology Laboratory at the USDA HNRCA, Caren E. Smith, M.S., D.V.M., scientist II in the Nutrition and Genomics Laboratory at the USDA HNRCA, Adela Hruby, Ph.D., M.P.H., scientist II in the Nutritional Epidemiology Laboratory at the USDA HNRCA, and Edward Saltzman, M.D., scientist II in the Energy Metabolism Laboratory at the USDA HNRCA at Tufts University and academic dean for education at the Friedman School.

The study was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health's Framingham Heart Study (award N01HC25195), Boston University School of Medicine and the United States Department of Agriculture's Agricultural Research Service.

Ma et al. "Sugar-Sweetened Beverage but Not Diet Soda Consumption Is Positively Associated with Progression of Insulin Resistance and Prediabetes." J. Nutrition 2016; 146:1-7. doi:10.3945/jn.116.234047

About the Jean Mayer USDA Human Nutrition Research Center on Aging and the Friedman School of Nutrition Science and Policy

For three decades, the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University has studied the relationship between good nutrition and good health in aging populations. Tufts research scientists work with federal agencies to establish the USDA Dietary Guidelines for Americans, the Dietary Reference Intakes, and other significant public policies. The Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University is the only independent school of nutrition in the United States. The school's eight degree programs -- which focus on questions relating to nutrition and chronic diseases, molecular nutrition, agriculture and sustainability, food security, humanitarian assistance, public health nutrition, and food policy and economics -- are renowned for the application of scientific research to national and international policy.

Tufts University, Health Sciences Campus

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.